A-kinase anchoring proteins (AKAPs) are a family of proteins that provide spatiotemporal resolution of protein kinase A (PKA) phosphorylation. In the myocardium, PKA and AKAP18/ are found in complex with sarcoendoplasmic reticulum Ca 2+ -ATPase 2 (SERCA2) and phospholamban (PLB). This macromolecular complex provides a means by which anchored PKA can dynamically regulate cytoplasmic Ca 2+ release and re-uptake. For this reason, AKAP18/ presents an interesting drug target with therapeutic potential in cardiovascular disease. The crystal structure of the central domain of human AKAP18 has been determined at the atomic resolution of 1.25 Å . This first structure of human AKAP18 is trapped in a novel conformation by a malonate molecule bridging the important R-loop with the 2H phosphoesterase motif. Although the physiological substrate of AKAP18 is currently unknown, a potential proton wire deep in the central binding crevice has been indentified, leading to bulk solvent below the R-loop. Malonate complexed with AKAP18 at atomic resolution provides an excellent starting point for structure-guided drug design.
Introduction
A-kinase anchoring proteins (AKAPs) are a family of proteins that control the spatiotemporal organization of protein kinase A (PKA) in the cell (Beene & Scott, 2007; Taské n & Aandahl, 2004) . This enzyme is the principal target for cyclic adenosine monophosphate (cAMP), which is synthesized by adenylyl cyclases in the plasma membrane. Accumulation of cAMP within subcellular microdomains mandates the need to sequester the kinase within these areas and hence control its intracellular location (Zaccolo & Pozzan, 2002) . AKAPs fulfil this function through complex association with PKA and other proteins and by their ability to tether these macromolecular complexes to intracellular membranes, the cytoskeleton and organelles (Wong & Scott, 2004) . Because of their central role in organizing cAMP-dependent signalling events, AKAPs are now recognized as fundamental elements of most second messenger-responsive signalling pathways. For example, in the myocardium AKAP18 sequesters PKA with its substrates sarcoplasmatic reticulum Ca 2+ -ATPase 2 (SERCA2) and phospholamban (PLB) (Lygren et al., 2007) . This AKAP18-PKA-SERCA2-PLB signalosome is a key modulator of Ca 2+ signalling in myocytes during excitation-contraction coupling and is therefore of therapeutic interest in cardiovascular diseases.
A defining feature of all AKAPs is the presence of an amphipathic helix that forms a complex with the docking/ dimerization (D/D) domain of the regulatory subunit of PKA
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# 2016 International Union of Crystallography (Carr et al., 1991) . This molecular interface is responsible for irreversibly binding to the PKA holoenzymes. Selective targeting of AKAP signalling complexes to specific subcellular locations is mediated by protein-protein or protein-lipid interactions in other regions of the anchoring protein (Langeberg & Scott, 2015) . Further diversity in AKAP assemblies is provided by the differential expression of alternately spliced forms. AKAP18 is found in four splice variants termed , , and . AKAP18 and AKAP18 are the longer variants and features a conserved central domain, AKAP18 CD , consisting of $200 amino acids. The complete AKAP18-PKA holoenzyme complex was recently determined by electron-microscopy single-particle reconstruction and shows that the AKAP18-D/D domain complex and the RIIPKAc complex domains are linked by large intrinsically disordered regions that retain intermolecular movement (Smith et al., 2013) .
The structure of the central domain of AKAP18 from Rattus norvegicus has been determined in apo, AMP-bound and CMP-bound states (Gold et al., 2008) . These structures revealed a single-domain fold with a central cleft for the binding of AMP and CMP. Alignment with 2H phosphoesterase revealed a conserved fold and two His-X-Thr motifs required for phosphoesterase activity and suggest that the central domain may possess phosphoesterase activity. From sequence alignment, these have been shown to be conserved across species (Gold et al., 2008) . Here, we report the central domain of human AKAP18 (hAKAP18 CD ) trapped in the apo form by malonate at a resolution of 1.25 Å . The atomic resolution crystal structure is the first human representation of AKAP18. The R-loop and 2H phosphoesterase motif are bridged by a malonate molecule and thus are fixed. The highresolution data allow us to confidently map a distinct water channel running in the bottom of the substrate-binding cleft, a water channel that may be modulated by the (V/A)G(E/ D)SR(S/T) motif present in the R-loop.
Materials and methods

Macromolecule production
Primers for the ligation-independent cloning (LIC) of residues 71-288 encoding the central domain (CD) of human AKAP18 (UniProt code Q9P0M2-1) into the pET-46 Ek/LIC vector (Novagen) were used. The construct was designed for the production of an N-terminally 6ÂHis-tagged fusion protein termed hAKAP18 CD . A Tobacco etch virus (TEV) cleavage site was introduced for removal of the 6ÂHis tag. The hAKAP18 CD construct was transformed into the Escherichia coli expression strain BL21-CodonPlus (Agilent Technologies). An overnight culture of 100 ml Luria-Bertani (LB) medium containing chloramphenicol (35 mg ml À1 ) and ampicillin (50 mg ml
À1
) was inoculated with a single colony of transformed E. coli BL21 cells. The overnight culture was diluted in 9 l LB medium with antibiotics as previously and 1 ml polyethylene glycol (an antifoam agent). The fermentation was left to grow until the optical density at 600 nm reached $1. The medium was chilled to 18 C and protein expression was induced with 1 mM IPTG. The cells were harvested after $18 h by centrifugation (9300g, 12 min), yielding $60 g wet weight of cells, which were stored at À80 C until use.
The cells were thawed on ice and 10 ml lysis buffer [500 mM NaCl, 100 mM Tris-HCl pH 8.0, 1 mg ml À1 DNAse I, 1 mM PMSF, 5 mM -mercaptoethanol, 1Â EDTA-free proteaseinhibitor cocktail tablet (Roche), 40 mM imidazole] was added per gram of pellet. All chemicals were purchased from Sigma unless stated otherwise. The cells were lysed by forcing the suspension three times through a high-pressure homogenizer (Emulsiflex C3, Avestin). Cell debris was removed from the crude extract by centrifugation for 1 h at 200 000g. (Ni-NTA column, GE Healthcare) in equilibration buffer (500 mM NaCl, 20 mM Tris-HCl pH 8.0, 40 mM imidazole, 5 mM -mercaptoethanol) using an Ä KTAprime FPLC system. The column was washed with ten column volumes (CV) of equilibration buffer and the 6ÂHis-tagged protein was released with elution buffer (500 mM NaCl, 20 mM TrisHCl pH 8.0, 300 mM imidazole, 5 mM -mercaptoethanol). The peak fractions were collected and evaluated by SDS-PAGE. GFP/His-tagged TEV protease was added in a 1:50 ratio and dialyzed overnight against dialysis buffer (500 mM NaCl, 15 mM Tris-HCl pH 8.0, 5 mM -mercaptoethanol, 40 mM imidazole). The digested protein was again loaded onto a pre-equilibrated Ni 2+ -affinity column and the flowthrough fraction containing the untagged hAKAP18 CD was collected. The protein was concentrated (10 kDa MWCO Vivaspin filter, GE Healthcare) and the concentrated sample was loaded onto a Superdex 200 HiLoad 10/600 prep-grade column as a final purification step using an Ä KTApurifier HPLC system. UV absorption was recorded at 280 nm. Fractions containing the purified protein were collected and its purity was determined by SDS-PAGE. SDS-PAGE analysis of various steps of purification and a size-exclusion chromatogram are shown in Fig. 1 . Macromolecule-production information is given in Table 1 .
Crystallization
Purified hAKAP18
CD was concentrated to 20 mg ml À1 , including a shift in the buffer conditions to 500 mM NaCl, 5 mM Tris-HCl pH 8.0, 1 mM DTT, using a 10 kDa MWCO Vivaspin column (GE Healthcare) in an Allegra X-22R centrifuge (Beckmann Coulter) at 3000g at 4 C. Concentration was measured with a NanoDrop 2000 (Thermo Scientific) using a predicted extinction coefficient of 14 440 M À1 cm À1 . Crystallization was performed by vapour diffusion in a sittingdrop setup in a 24-well plate (Hampton Research) in accordance with Table 2 . The plate was sealed with Crystal Clear tape (Hampton Research) and placed at 18 C. Crystals appeared within 5 d. Single crystals were mounted using a LithoLoop (Molecular Dimensions) of suitable size, flashcooled directly from the drops without the need for additional cryoprotectant and stored in liquid nitrogen at 100 K.
Data collection and processing
Diffraction data collection was carried out on beamline ID30B at the European Synchrotron Radiation Facility (ESRF), Grenoble, France. The beamline features a Dectris Pilatus 6M detector. The crystal lattice was determined to be primitive orthorhombic and a data-collection strategy was performed in iMosflm (Battye et al., 2011) . A data set was collected at 1.25 Å resolution. Data reduction was performed using xia2 (Winter et al., 2013) in space group P2 1 2 1 2 1 . Datacollection and processing statistics are collected in Table 3 .
Structure solution and refinement
The Matthews coefficient of 2.3 Å 3 Da À1 indicated the presence of one molecule in the asymmetric unit with a solvent content of 47% (Kantardjieff & Rupp, 2003) . The data were phased using the apo form of rat AKAP18 (rAKAP18; PDB entry 2vfy; Gold et al., 2008 ) as a search model. rAKAP18 shares 83% sequence identity with hAKAP18 Table 1 Macromolecule-production information.
A TEV protease site was included in the forward primer and is underlined in the sequence. The cleavage site is denoted |.
Source organism
Homo sapiens DNA source Synthesized (GenScript) Forward primer
GACGACGACAAGATGGAGAATCTTTATTTTCAGGGCGA-TCAAGTAAAGAAGAGGAAAAAA
Reverse primer
GAGGAGAAGCCCGGTTAGTTCTTTTCACCAATCACAAT-GG
Expression vector pET-46 Ek/LIC Expression host E. coli BL21 Rosetta2 Construct sequence
MAHHHHHHVDDDDKMENLYFQ|GDQVKKRKKKRKDYQP-
NYFLSIPITNKEIIKGIKILQNAIIQQDERLAKAMV-SDGSFHITLLVMQLLNEDEVNIGIDALLELKPFIEE-LLQGKHLTLPFQGIGTFGNQVGFVKLAEGDHVNSLL-EIAETANRTFQEKGILVGESRSFKPHLTFMKLSKSP-WLRKNGVKKIDPDLYEKFISHRFGEEILYRIDLCSM-LKKKQSNGYYHCESSIVIGEK Table 2 Crystallization. 3. Results and discussion 3.1. The structure of human AKAP18c
CD
The crystal structure of human AKAP18 CD (hAKAP18 CD ) was refined to a final R cryst and R free of 0.161 and 0.180, respectively. Validation using MolProbity (Chen et al., 2010) showed that 99.1% of the residues are located in Ramachandran favoured regions. The structure features a central crevice flanked by two antiparallel -sheets composed of strands 1-2-5-8-9 and 3-4-6-7, respectively. These sheets are flanked by -helices on the side facing away from the crevice (Fig. 2a) . hAKAP18 CD is locked in an apo state with no AMP present in the binding pocket; rather, a malonate molecule (M1) occupies this binding crevice. In addition, five additional malonate molecules (M2-M6) were identified; however, their positions appear to be less defined in the electron density. Furthermore, they are not located in the immediate proximity of the R-loop. Their locations on the surface of hAKAP18 CD are presented in Supplementary  Fig. S1 .
Comparison of human AKAP18c
CD with rat AKAP18d CD Superposition of the rat and human structures show that the overall fold of hAKAP18 CD is equivalent to the structure of apo rAKAP18 CD , with an overall r.m.s.d. value of 0.81 Å Table 4 Structure solution and refinement. (Fig. 2a) . The only differences include the displacement of a highly conserved loop region, termed the R-loop, found between -sheet 5 and -helix 3, and a minor displacement of the 3/4 loop. The relative displacement in the R-loop is 5.0 Å (hAKAP18 CD Arg214 C to rAKAP18 CD Arg214 C ). A difference density (F o À F c ) OMIT map covering the R-loop is included in Fig. 2(a) and indicates the new position. In the structures of AMP-bound and CMP-bound rat AKAP18 CD (PDB entries 2vfk and 2vfl; Gold et al., 2008) , the conserved residues Arg214 and Phe174 of hAKAP18 CD form stacking interactions with the aromatic adenine and cytosine moieties. The majority of the side chain of Arg214 could not be traced in the electron density of rAKAP18 CD , and only backbone and C atoms are modelled. However, in the apo form of hAKAP18 CD the side chain of Arg214 forms astacking interaction with the phenyl ring of Phe174. The distance between Arg214 N " and Phe174 C was measured to 3.9 Å . Furthermore, this interaction places the positively charged guanidinium moiety of Arg214 in the proximity of a negatively charged malonate molecule found in the crevice. At pH 7.0 and with a distance between the guanidinium and the carboxylate of the malonate of 3.5 Å , an electrostatic interaction is present (Fig. 2b) . The malonate molecule is further anchored by hydrogen bonding to the side-chain hydroxyl of Thr29, His219 and Thr221. The stacking interaction and local stabilization provided by the malonate are the likely cause of the overall conformational change of the loop.
The malonate complex resembles the AMP-bound form of human AKAP18cCD
Superposition of the AMP-bound form of rAKAP18 CD reveals that the guanidinium moiety and the malonate molecule occupy equivalent positions to N9 of the adenine moiety and the phosphate group, respectively (Fig. 2b) . Attempts have been made to obtain a crystal structure of the AMPbound form of hAKAP18 CD ; however, under the present crystallization conditions AMP may have been displaced by the high concentration of malonate. Since there is a report of AKAP18 complexes that lack AMP and GMP in the central crevice (Ezerski, 2011) , it is possible that both nucleotide adducts are opportunistic interactors rather than physiological ligands. Nonetheless, the prevailing view is that hAKAP18 CD acts as a low-affinity AMP sensor in vivo and it is possible that the AMP-bound form can be mimicked by the presence of malonate to some extent. Mapping of amino-acid differences between hAKAP18 CD and rAKAP18
CD
. Differences are highlighted in orange. R-loop and 3/4-loop residues are highlighted in red and yellow, respectively.
Malonate ligands as input for fragment-based drug screening
It is likely that competition with AMP binding will have functional implications for the biology of hAKAP18. Hence, the malonate molecule can be used as a starting point for fragment-based drug discovery. The dimensions and charge distribution of malonate seem to be ideal to bridge the aromatic recognition motif (Arg214 and Phe174) with the 2H phosphoesterase motif. From structural alignment of hAKAP18 CD and rAKAP18 CD , it is found that sequence variation is found primarily on the surface of the protein and that the residues lining the central crevice are completely conserved (Fig. 3) . In addition, the deviating residues appear to cluster at one end of hAKAP18 CD . This may indicate an as yet unappreciated function for these conserved surfaces. Consequently, inhibitors developed against the nucleotidebinding site may first aid in elucidating the physiological role of AKAP18 and subsequently have significant therapeutic potential.
3.5. The active site of hAKAP18cCD contains a putative proton wire
The presence of the 2H phosphoesterase motif formed by Thr127, His129, His219 and Thr221 indicates that hAKAP18 CD has enzymatic activity; however, its physiological substrate remains unknown. Earlier studies noted a structural similarity to the active site of 2 0 ,3 0 -cyclic nucleotide 3 0 -phosphoesterase (CNPase; Myllykoski et al., 2012) . One feature shared between CNPase and hAKAP18 CD is the hydrated substrate-binding crevice. The water found in the binding crevice of hAKAP18
CD links directly to bulk solvent through the R-loop (Fig. 4a) . Studies of the catalytic mechanism of CNPase describe the activation of a water molecule prior to nucleophilic attack on the substrate (Myllykoski et al., 2013) . This activation requires the abstraction of a proton from the catalytic site, and it is possible that water plays a role in its efficient removal through a proton wire formed by the chain of water molecules. The positions of waters W19, W4, W1 and W18 and W15 are relatively conserved between rAKAP18 CD and hAKAP18
CD
. The water positions below the R-loop (W109, W120, W10, W70 and W72) are not conserved, which is likely to reflect the variability in the position of the loop and the rearrangement of the local water structure. All distances between water molecules are compatible with hydrogen bonding except for the distances W3-W4 (3.3 Å ) and W6-W7 (3.5 Å ). One may hypothesize that the correct substrate may arrange the water molecules in this region in a way that may complete the proton wire. This may also explain not only why Arg214 is conserved in the loop, but that the entire loop is composed of a consensus motif (V/A)G(E/D)SR(S/T), which is either completely conserved or with functionally conserved residues, as shown by the alignment (Fig. 4b) .
In summary, we have determined the crystal structure of the central domain of human AKAP18 at 1.25 Å resolution. The structure reveals a similar fold to that previously determined from rat AKAP18. However, the R-loop region carrying the important residue Arg214, which is involved in interaction with AMP, has moved to a position stabilized by the binding of malonate. The local water structure below the R-loop is rearranged depending on the position of the loop and may be of catalytic importance. The interaction between Phe174 and Arg214 combined with the position of the malonate molecule in stabilization leads to the suggestion that this state of hAKAP18 CD resembles the AMP-bound form to some extent. This observation may be of further use in investigation of the role of hAKAP18 in AMP sensing and in drug screening. Water structure in the nucleotide-binding crevice and conservation of the R-loop. (a) Waters (red) line the bottom of the crevice, forming a hydrated path leading from the 2H phosphodiesterase motif to bulk solvent through the R-loop (red). Water-water distances that are longer than normal hydrogen bonds are labelled. The water structure of hAKAP18 CD and rAKAP18 CD (red and purple) is highly conserved around the active site, whereas the dislocation of the R-loop affects the local water structure beneath the loop. (b) The R-loop is functionally conserved with the consensus motif (V/A)G(E/D)SR(S/T). Completely conserved residues of the regions flanking the R-loop are marked in blue. These are involved in maintaining the fold of the 2H phosphodiesterase motif. The R-loop is marked with a red bar.
